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and §Physical Biosciences and Materials Sciences Divisions, Lawrence Berkeley National Laboratory, Berkeley, CaliforniaABSTRACT The receptor tyrosine kinase EphA2 interacts with its glycosylphosphatidylinositol (GPI)-linked ephrin-A1 ligand in
a juxtacrine configuration. The soluble ephrin-A1 protein, without its GPI membrane linker, fails to activate EphA2. However,
preclustered ephrin-A1 protein is active in solution and has been frequently used to trigger the EphA2 receptor. Although this
approach has yielded insights into EphA2 signaling, preclustered ligands bypass natural receptor clustering processes and
thus mask any role of clustering as a signal regulatory mechanism. Here, we present EphA2-expressing cells with a fusion
protein of monomeric ephrin-A1 (mEA1) and enhanced monomeric yellow fluorescent protein that is linked to a supported lipid
bilayer via a nickel-decahistidine anchor. The mEA1 is homogeneously dispersed, laterally mobile, andmonomeric as measured
by fluorescence imaging, correlation spectroscopy, and photon counting histogram analysis, respectively. Ephrin-A1 presented
in this manner activates EphA2 on the surface of MDA-MB-231 human breast cancer cells, as measured by EphA2 phosphor-
ylation and degradation. Spatial mutation experiments in which nanopatterns on the underlying substrate restrict mEA1 move-
ment in the supported lipid bilayer reveal spatio-mechanical regulation of this signaling pathway, consistent with recently
reported observations using a synthetically cross-linked ephrin-A1 dimer.INTRODUCTIONEph receptor tyrosine kinases, through binding to either
glycosylphosphatidylinositol (GPI)-linked or transmem-
brane ephrin ligands, are important regulators of cell adhe-
sion, migration, and vascular development (1). Eph and
ephrin interactions have been shown to both suppress and
promote cancer formation by altering cell repulsion
and migration (2). In particular, EphA2 and its GPI-linked
ligand ephrin-A1 are important in maintaining many
different tumor types (3). Overexpression of EphA2 in non-
transformed mammary epithelial cells confers malignant
transformation and tumorigenic potential (4,5). Decreasing
expression of EphA2 can reverse metastatic behavior in
immortal breast epithelial cell lines (6). In addition to these
pro-oncogenic properties of overexpressed EphA2, this
receptor has also been shown to suppress tumorigenesis.
For example, EphA2 knockout mice are more susceptible
to develop skin cancer upon exposure to known carcinogens
(7). These findings, among others, have ledEphA2 to become
a target for cancer therapeutics.
EphA2 consists primarily of an intracellular kinase
domain, an extracellular ligand-binding domain, and a trans-
membrane domain (8). Activation of EphA2 is marked by
phosphorylation of the kinase domain (9) and can lead to
receptor internalization and degradation through the recruit-
ment of metalloproteases to the cell membrane (10).
Ligand-induced receptor activation occurs upon the binding
of EphA2 to its ephrin-A1 ligand presented on apposed cell
membranes. Ligand binding is generally followed by dimer-Submitted April 27, 2011, and accepted for publication October 31, 2011.
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0006-3495/11/12/2731/9 $2.00ization of the receptor-ligand complex, oligomerization as
a result of three distinct ligand binding sites on the receptor
(11), and possibly larger scale cell surface reorganization
(12). The clustering and subsequent endocytosis of EphA2
has been hypothesized as a method of regulating cell surface
EphA2 levels (13). Ligand-induced receptor clustering has
been proposed as a likely source of signal regulation that
is independent of any conformational changes within the
receptor and therefore a potential deregulatory mechanism
in Eph-overexpressing tumors (14).
The hybrid live cell-supported lipid bilayer (SLB) junc-
tion, in which one cell surface in a juxtacrine signaling
process is replaced by a SLB displaying ligands of interest,
has proven to be an effective strategy to examine cell-cell
signaling (12,15–18). SLBs can be formed by the sponta-
neous self-assembly of a phospholipid bilayer upon deposi-
tion of vesicles onto a silica support (19,20). The resulting
membrane is continuous and fluid, with lipid lateral mobil-
ities typically ranging from 1 to 3 mm2/s (21,22). GPI-linked
proteins can be incorporated into SLBs without loss of
mobility (23). In many cases, including the work presented
here, protein linkage to the membrane by multivalent inter-
actions between decahistidine tails on the protein and
Ni-chelating lipids in the membrane is equally effective
(24), and technically much simpler (25,26). We have
recently used the live cell-SLB junction, functionalized
with a preclustered EA1 ligand, to study properties of
EphA2 signaling (12). This work revealed that the EphA2
signaling pathway is sensitive to the physical restriction
of receptor-ligand movement over micron length scales
within the plane of the cell-SLB interface. These results
raise interesting hypotheses concerning the possibility ofdoi: 10.1016/j.bpj.2011.10.039
2732 Xu et al.mechanosensing in relation to EphA2 signaling and they
also underscore the importance of large-scale receptor
assembly as a regulatory component of signaling. In this
regard, however, the use of preclustered ligands is especially
problematic because it essentially bypasses natural receptor
assembly processes.
Eph receptors bind to ephrin ligands as a 1:1 complex
(27) and can be activated by ephrin expressed on cell
membranes or in a preclustered format (28). Soluble mono-
meric ephrin has generally been considered inactive.
However, a recent report suggests that the media containing
soluble and monomeric ephrin-A1, released from tumor
cells, through possible cleavage processes, is capable of
activating EphA2 in paracrine signaling (29). These contra-
dictory findings underscore the complexity of Eph/ephrin
interactions. Based on prior observations of inactive mono-
meric protein ligands becoming active in juxtacrine
signaling from supported membranes, for example major
histocompatibility complex in T cell receptor signaling
(30) and neuroligin in neurexin signaling (31), we hypothe-
sized that laterally mobile and monomeric ephrin-A1 pre-
sented on a supported membrane may activate the EphA2
receptor in the absence of synthetic cross-linking agents.
Furthermore, this platform will provide a useful tool to
study the signaling pathway and the effects of natural
receptor clustering processes.
We constructed a fusion protein of monomeric ephrin-A1
(mEA1), enhanced yellow fluorescent protein (EYFP), and
a 10-histidine (H10) tail. We have previously shown that
H10 tails can form essentially irreversible multivalent
linkage with Ni-chelating lipids in SLBs when assembled
using kinetically controlled parameters (26). Fluorescence
imaging of the mEA1-EYFP-H10 fusion protein in SLBs
reveals that it is homogeneously distributed. Fluorescence
correlation spectroscopy confirms that it is laterally mobile
with a diffusion coefficient similar to that of the lipids,
and photon counting histogram analysis reveals the protein
to be predominantly monomeric on the membrane surface.
The supported membrane-associated mEA1 activates the
EphA2 receptor signaling pathway in live EphA2-express-
ing human breast cancer cells (MDA-MB-231), as mea-
sured by receptor phosphorylation and degradation. The
soluble mEA1 is inactive in these experiments. Addition-
ally, spatial mutation experiments in which nanopatterned
structures on the underlying substrate are used to manipulate
the movement and assembly of receptor-ligand complexes
reveal spatio-mechanical influences over the EphA2
signaling pathway similar to recently reported observations
using a synthetically cross-linked ephrin-A1 dimer, EA1-Fc
(12). Large-scale EphA2/ephrin-A1 assembly occurs during
activation even without any preclustering of the ligand and
mechanical interference with this process leads to distinct
alterations in cell behavior, as observed by cytoskeleton
morphology and recruitment of the metalloprotease,
ADAM10.Biophysical Journal 101(11) 2731–2739MATERIALS AND METHODS
This section has been moved to the Supporting Material.RESULTS AND DISCUSSION
EA1 association with supported membranes
is stable and properly oriented
The EA1 fusion protein is expressed by combining the
human monomeric EA1 ectodomain sequence, along with
the EYFP sequence (as a 1:1 construct between EA1 and
EYFP), with an H10 tail on the C-terminus for linkage to
Ni-chelating lipids, which are incorporated into the sup-
ported membrane at molar ratios ranging from 0.005 to
0.06 (Fig. 1 A and Fig. S1 in the Supporting Material).
Multivalent Ni-histidine interactions are necessary to stably
associate protein through this method (Fig. 1 A inset) (26).
Typically, protein is incubated under carefully tuned kinetic
control parameters to optimize for multivalent interactions.
It is also generally necessary to allow a desorption period to
remove weakly associated protein. Although equilibrium is
never fully reached, stable multivalently bound His-tagged
proteins can be achieved with reproducible results. A
Ni-histidine dissociation curve is generated to show that
the mutlivalent Ni-bound protein remains stably bound
to the SLB for at least 16 h (Fig. 1 B). The protein linkage
through histidine-chelated Ni interactions is confirmed by
the addition of 100 mM EDTA, which strongly sequesters
metal ions and leads to dissociation of protein bound in
this manner (Fig. 1 B).EA1 is mobile and predominantly monomeric
in supported membranes
Fluorescence correlation spectroscopy (FCS) along with its
counterpart photon counting histogram (PCH) analysis offer
a powerful means to quantify the lateral mobility and the
cluster size distribution of EA1 on the SLB surface (32).
A typical time autocorrelation function of fluorescence
intensity fluctuations from membrane-bound EA1 is plotted
in Fig. 2 A. The data is fitted to an analytical expression of
normal two-dimensional diffusion in a two-dimensional
Gaussian illumination spot,
GðtÞ ¼ 1
Nave
 1
1þ t=tD; (1)
where Nave represents the average number of independent
molecules, t is the time interval, and tD represents the char-
acteristic residence time (33). Based on this model, the
calculated diffusion coefficient for membrane EA1 is
2.3 5 0.2 mm2/s. This value is typical for lipid diffusion
in supported membranes (34) and also consistent with
fluorescence recovery after photobleaching experiments
(Fig. S2). Although tempting, one should not infer from
this observation that the protein is monomeric. For FCS to
FIGURE 1 Schematic diagram of the experimental setup. (A) EphA2-expressing breast cancer cells are cultured on a SLB consisting of a tunable surface
density of EA1 fusion proteins. This fusion protein is designed by linking the soluble portion of monomeric human ephrin-A1 with enhanced YFP that has an
A206Kmutation to prevent dimer formation. The inset shows the anchoring strategy, which is stable when the decahistidine sequence at the C-terminus of the
fusion protein is chelating multiple Ni ions that are chelated by a tunable subset of lipids within the bilayer. (B) Ni-histidine dissociation curve shows that
protein binding reaches a kinetically trapped state (plateau in graph between 3 and 16 h) that is stable and therefore insensitive to rinsing steps well beyond
the timescale of experiments. The bilayer is incubated at 25C for the entirety of the measurements except for an hour at 37C in warm cell media after the
first 2 h. The high temperature incubation period is performed to mimic the period after cells are introduced and then incubated at 37C for an hour.
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a significant and well-defined difference in mobility is
necessary (35). Because the EA1 is anchored to the
membrane, its mobility is dominated by the membrane
(36). As such, there is no well-defined scaling of molecular
mobility with size and furthermore, the effective size of
dimers, trimers, etc., is not at all clear (37). In light of these
complexities, molecular mobility is an unreliable indicator
of molecular size or state of clustering.
Direct analysis of the distribution of photon arrival times
(PCH) emitted by the EYFP molecules (that are genetically
fused to EA1) diffusing through the open confocal spot
provides a significantly more sound method of determining
the aggregation state of EA1 (Fig. 2 B). The fluorescence
intensity fluctuations caused by the EYFP molecules
yield a super-Poisson (Poi) distribution of photon counts
arriving at the detector for a given time interval (38). By
choosing a time interval that is short relative to the timescale
for molecules to move through the laser spot, the PCH
reflects the cluster size distribution and, importantly, is inde-
pendent of mobility. The probability distribution of a single
molecule, p(1), diffusing within a closed system, V0, is
expressed as
pð1Þðk;V0; εÞ ¼
Z
Poiðk; εPSFð r/ÞÞpð r/Þd r/; (2)where PSF is the scaled point spread function for synchro-
nizing the PCH volume with the FCS volume, pð r/Þ repre-
sents the probability to find the molecule at position r
/
, k
is the detected photon count, and ε is the molecular bright-
ness of the molecule. For N independent and identical mole-
cules, the joint probability distribution p(N) is calculated
from consecutive convolutions of p(1). It is expressed as
pðNÞðk;V0; εÞ ¼

p
ð1Þ
1 5.5p
ð1Þ
N

ðk;V0; εÞ: (3)
It is numerically easier and equally accurate to select
a reference volume (V1) that is smaller than the reservoir
(V0) for deriving the PCH probability distribution so that
the N value can remain small (38). The probability distribu-
tion for multiple molecules in an open system is the expec-
tation value of p(N), which is weighted by the Poissonian
probability, p#(N), of observing N particles,Y
ðk;NPSF; εÞhbpðk;V1;N; εÞ ¼ pðNÞðk;V1; εÞN
¼
XN
N¼ 0
pðNÞðk;V1; εÞp#ðNÞ; (4)
where the change from N to NPSF reflects the selection of
a V1 that is smaller than V0. This change does not affect
the photon count probability because this probability of anBiophysical Journal 101(11) 2731–2739
FIGURE 2 Characterization of mEA1-SLB surface heterogeneity and
protein cluster size. (A) FCS is used to determine the heterogeneity of the
surface. Values are fitted to a standard two-dimensional, single component
curve. The diffusion constant calculated for the majority species is compa-
rable to protein diffusion constants on cell membranes in vivo. A derivation
of the autocorrelation function is used to relate the fraction of monomer
to the average aggregation number (Q). From two independent FCS
experiments, the derived function predicts that the fraction of monomeric
species is 77 5 7% for a Q value of three. (B) The PCH is best fit by a
two species fit. The majority of the surface protein molecules (76 5 5%)
exhibit an average fluorescence intensity corresponding to a single EYFP
flourophore, indicating that the majority of the species exists as monomer
fusion proteins. This percentage is an average across three independent
PCH experiments.
2734 Xu et al.open system is independent of the volume V1 as long as this
probability can be referenced to the concentration of the
molecule (38). In the case of membrane EA1, an accurate
independent measurement of the surface density of EA1 is
required to determine the N. This is achieved using quanti-
tative fluorescence (QF) microscopy, which calibrates
fluorescence from the membrane-bound analyte with fluo-
rescent lipid standards with known membrane surface densi-
ties (39). Once this value is determined through QF, it is
inserted into Eq. 4 and the resulting probability distribution
is used to fit the membrane EA1 PCH. Because the PCH
analysis has been experimentally demonstrated to be
capable of resolving the aggregation state of fluorescent
proteins (40), given an accurate value of N, both the average
aggregation state (Q) and fraction (F) of monomeric EA1
can be determined from the best fit probability distribution,
which has a local c2 value closest to one. Interestingly, the
relationship between Q and F can be separately derived
from the G(0) of the autocorrelation function for a two-
component model asBiophysical Journal 101(11) 2731–2739Gð0Þ ¼ Qþ Fð1 QÞ
N
; (5)
where N is determined by QF measurements and G(0) is
calculated from Eq.1 as 1=Nave (see the Supporting Material
for derivation). Therefore, for a given integral value of Q,
the F value can be predicted by Eq. 5.
The precision with which both FCS and PCH can deter-
mine the surface density is characterized using lipid bilayer
standards (Fig. S3, A–B). FCS and PCH results are in precise
agreement with each other as well as the known surface
densities for boron-dipyrromethene (Bodipy) fluorescent
dyes bound to the headgroups of phospholipid molecules
incorporated into the bilayer at molar ratios of 0.0001,
0.0002, and 0.0004, (Fig. S3, C–D). For these standards,
the fluorescent lipid molecules are expected to move as
monomers, in which case N is simply the number of mole-
cules. Using these three standard lipid membranes, QF is
performed to determine the surface density of membrane
EA1. Calibration of spectral properties between the YFP
fluorophore on EA1 and the lipid standard is performed in
solution to obtain a scaling factor (39) of 0.7 (Fig. S4 A).
This relationship is linear at unsaturated fluorophore
concentrations (39), enabling direct extrapolation to deter-
mine the EA1 surface density from measured fluorescence
intensity (Fig. S4 B). When N determined from surface
density measurements by QF is used to interpret the two
species autocorrelation function (Eq. 5), 77 5 7% of EA1
is found to be monomeric (mEA1) and the remaining 13%
has a Q value of 3 (trimers). Similarly, the best probability
distribution fit to the PCH data is a two species curve result-
ing in an average local c2 of 1.0 5 0.2, corresponding to
76 5 5% mEA1 with Q also equal to 3. The EA1 domain
itself appears to be responsible for this clustering based
on comparison to a similar fusion protein containing the
extracellular domain of intercellular adhesion molecule 1
(ICAM) fused to YFP-H10 (ICAM-YFP-H10) (26,41).
Both FCS and PCH analyses indicate ICAM-YFP-H10 to
remain ~100%monomeric under similar conditions (Fig. S5
and Fig. S6).
To gauge the precision of this methodology to determine
clustering state, probability distributions are also calculated
for cases of several different aggregation states: solely
monomeric, dimeric, or trimeric EA1. The respective resid-
uals are plotted in Fig. S6. The resolution of PCH in distin-
guishing between aggregation states can be revealed in
the poor c2 values of these cases. We conclude from two
independent methods that the membrane-associated EA1
is predominantly monomeric.EphA2 activation by membrane-associated EA1
After careful characterization of the membrane-associated
EA1 surface, MDA-MB-231 cells, a highly invasive breast
epithelial cancer cell line that overexpresses EphA2 (42),
FIGURE 3 Surface density titration of mEA1 and immunofluorescence
images of MDA-MB-231 cells. (A) The surface density of mEA1 is
achieved by varying the solution incubation concentration above the bilayer
and the molar ratio of Ni capturing lipids within the bilayer through kinetic
control parameters. The surface density measurements are performed using
quantitative fluorescence microscopy. (B) MDA-MB-231 cells are fixed and
permeabilized after 15-min incubations on these surfaces. Antibodies
against phosphorylated tyrosine residues (pY) and EphA2 are used to detect
phosphorylation at the regions of mEA1 cluster formation and to stain for
the presence of EphA2, respectively. For high mEA1 surface densities
(thousands of molecules/mm2), phosphorylated proteins are recruited to
the mEA1 microclusters. At low mEA1 surface densities (hundreds of
molecules/mm2), EphA2 is also recruited. These results suggest that over
a range of surface densities, phosphorylated proteins and EphA2 colocalize
with mEA1 on the single cell level. A similar result is observed for EphA2
at high mEA1 surface densities and pY at low mEA1 surface densities;
recruitment of both molecules occurs over a range of mEA1 surface densi-
ties (results not shown). Scale bars are 10 mm.
EphA2 Activation by Monomeric Ephrin-A1 2735are cultured on this surface under similar conditions used for
the surface characterization, and its EphA2 activation is
measured. EphA2 triggering by membrane-associated eph-
rin-A1 has been previously characterized through the phos-
phorylation and degradation of this receptor tyrosine kinase
(12). These properties can be measured in two different
manners: i), fluorescence microscopy to image immuno-
stained signaling molecules colocalizing with EphA2, such
as phosphotyrosine and the metalloprotease ADAM10, and
ii), Western blot analysis to determine degradation and
phosphorylation of EphA2. In this case, both methods are
employed to determine EphA2 activation bymembrane asso-
ciated EA1.
First, to examine whether EphA2-expressing cells are
responsive to changes in ligand concentration, MDA-MB-
231 cells are incubated on different EA1 surfaces with
different surface densities that are representative of typical
cell surface concentrations of EA1. The EA1 surface density
can be titrated by changing both the solution incubation
concentration and the molar percent of Ni capturing lipids
incorporated into the supported membrane (Fig. 3 A). The
resulting mEA1 surface densities are measured using QF
microscopy as previously described (39). After 10 min of
incubation, the cells are fixed and permeabilized. Fluores-
cently labeled antibodies staining for EphA2 and phospho-
tyrosine are imaged using epifluorescence microscopy
(Fig. 3 B). These representative images show the formation
of EphA2 microclusters that colocalize with the microclus-
ters of mEA1, imaged for the same cell. Similarly, phospho-
tyrosine immunofluorescence also colocalizes with mEA1
microclusters. The EphA2 receptor expressed on the
membranes of MDA-MB-231 cells are interacting with
membrane mEA1 proteins and there are high levels of phos-
phorylation, suggesting EphA2 activation. This colocaliza-
tion is observed for mEA1 surface densities ranging from
just a few molecules to hundreds of molecules/mm2. The
membrane mEA1 fusion protein presented to MDA-MB-
231 cells is capable of initiating receptor phosphorylation
over a wide range of surface densities.
Next, the lateral reorganization and clustering of the
mEA1 fusion protein is examined over the course of an
hour. This incubation time is previously shown to be a useful
observation time for the central transport of membrane EA1
by EphA2 expressing cells (12). The EphA2 density on
the surface of MDA-MB-231 is approximately several
hundreds of molecules/mm2; the surface density for mEA1
is fixed at a similar value for these experiments. Cells
were fixed and permeabilized after incubations of 5, 10,
20, and 60 min for imaging (Fig. S7). At early time points
(5 and 10 min), Eph-ephrin clusters are generally micron-
sized or smaller and are randomly distributed across the
cell-SLB interface. Within 1 h of cell engagement, these
clusters coalesce into larger clusters that are transported to
the center of the cell-SLB interface, resulting in a central
contact zone several microns in diameter enriched inEph-ephrin complexes. Temporal progression of ADAM10
recruitment to Eph-ephrin clusters is examined through
staining cells with a fluorescently labeled anti-ADAM10
antibody. ADAM10 recruitment is a known step of the
EphA2 degradation pathway, and is thought to enzymati-
cally cleave the ephrin ligand from the ligand-presenting
surface (10). At early time points (5 and 10 min), most of
the ADAM10 is within the cell, well out of the focal
plane of the objective, resulting in a blurred ADAM10
signal observed using epifluorescence microscopy. At later
time points (20 and 60 min), we observe recruitment of
ADAM10 to the EphA2-mEA1 clusters. A qualitative anal-
ysis of the fluorescence microscopy images suggest thatBiophysical Journal 101(11) 2731–2739
2736 Xu et al.mEA1 leads to EphA2 phosphorylation and degradation as
mediated by ADAM10. Furthermore, these results suggest
that ADAM10 recruitment to Eph-ephrin clusters is
a dynamic process. Despite the presence of a small minority
of oligomeric EA1, the majority mEA1 is clearly active
because essentially all of the available EA1 on the supported
membrane is sequestered into EphA2 signaling clusters.
Finally, to contextualize these findings within the frame-
work of classical biochemical techniques, Western blotting
is used to examine EphA2 phosphorylation and degradation
across a wide range of mEA1 surface densities and preclus-
tered states (Fig. 4 and Figs. S8–S10). MDA-MB-231 cells
are incubated on surfaces displaying different surface densi-
ties and aggregation states of mEA1, including both
membrane bound as well as in solution. After 2 h incuba-
tions, the cells are lysed and the protein supernatant is
analyzed. On the basis of the Western blot analysis, we
interpret the lack of increased EphA2 downregulation as
no EphA2 downregulation. Exogenous dimerization is
introduced using an anti-green fluorescent protein mouse
monoclonal IgG2a antibody to cross-link mEA1-eYFP-
H10. A further degree of clustering is introduced through
the addition of a goat anti-mouse IgG2a antibody. At low
surface densities of EA1 (~100 molecules/mm2) on the
SLB, no significant EphA2 degradation or phosphorylation
is observed regardless of the degree of EA1 cross-linking.
Notably, this contrasts sharply with microscopy data, which
indicates strong activation at similar densities. We speculate
that Western analysis is not sufficiently sensitive to monitor
signaling at these lower EA1 levels.
When the EA1 surface density is increased 10-fold
(~1000molecules/mm2), EphA2 degradation and phosphory-
lation levels for mEA1 is measured at similar levels to those
observed in response to soluble EA1-Fc, the synthetically
cross-linked ephrin-A1 dimer. However, the membrane-
bound antibody cross-linked mEA1, designed to mimic theBiophysical Journal 101(11) 2731–2739EA1-Fc, is not as activating as theEA1-Fcpresented on a sup-
ported membrane through a Ni-histidine linkage. To explain
this discrepancy, the length scales of the two different cross-
linking strategies need to be examined. For the antibody
cross-linked mEA1, the distance between two antigen
binding sites of an antibody is ~10 nm (43), and this spacing
might be unfavorable for EphA2 activation. On the other
hand, the EA1-Fc dimer is linked by a disulfide bond, which
is ~0.1 nm in length. This observation is consistent with the
small length scales required for the recruitment of proteins
in Eph signaling that has been previously reported (44).
Similar to previous reports of the inactivity of soluble mono-
meric ephrin-A1 (28), we also observed inactivity of the
mEA1-eYFP-H10 in solution for both EphA2 degradation
and phosphorylation Western blot analyses. Although fluo-
rescence microscopy measurements suggest that EphA2
can be activated by membrane EA1 over a range of surface
densities, Western blot analysis is only capable of detecting
EphA2 activation at high densities of membrane EA1
because this analysis takes into account the fraction of total
cell surface EphA2 that is downregulated.Our results suggest
that activating a small fraction of EphA2 can initiate a full
cellular response.
To extend observations beyond the MDA-MB-231
cell line, the central transport of membrane mEA1 by
EphA2 expressing cells is also observed for other breast
cancer cell lines (Fig. S11). After an hour incubation
on supported membranes with EA1 surface densities of
~100 molecules/mm2, a similar EA1-bound EphA2 transport
leading to a central contact zone is observed. Immunofluo-
rescence images of EphA2 show the receptor colocalizing
with mEA1. The enchanced fluidity of the Ni-histidine
anchoring strategy allows for a kinetically faster central
transport as compared to the synthetically cross-linked eph-
rin-A1 dimer on supported membrane as demonstrated
previously (12).FIGURE 4 Western blots are analyzed from the
lysate of MDA-MB-231 cells incubated on
different surfaces and in different solutions. The
blots are stained for the presence of EphA2. In
this case, the degradation of EphA2 is represented
by the intensity of an EphA2 band between 75 and
150 kDa. The lower the band intensity, the greater
the receptor degradation. Intensity measurements
of EphA2 bands are repeated for at least four
unique Western blots and the results are averaged
across the blots. Soluble mEA1, over a range of
concentrations (results not shown), does not induce
significant EphA2 degradation, whereas mEA1 on
a SLB leads to EphA2 degradation. Antibody
cross-linked mEA1 on a SLB leads to EphA2
degradation, although to a lesser degree than pre-
clustered EA1-Fc. At low surface densities of
mEA1, Western blot analysis is unable to detect
significant EphA2 activation (Figs. S8–S10).
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spatio-mechanical dependency
Sensitivity of the EphA2 system to spatio-mechanical
perturbation is tested using the spatial mutation strategy.
Patterns of metal grids, prefabricated onto the underlying
substrate, restrict the lateral mobility of membrane mEA1
as well as ligand-engaged EphA2 receptors on the live
cell. Immunofluorescence images of phalloidin-labeled
actin and ADAM10 detected with epifluorescence and total
internal reflection fluorescence microscopies, respectively,
show the altered downstream signals as a consequence of
EphA2 spatial mutation. When Eph-ephrin clusters are
laterally constrained within corrals larger than five microns
in pitch, the actin cytoskeleton is concentrated in an
annulus, immediately peripheral to the Eph-ephrin central
assembly (Fig. 5 A), which is indicative of cell contraction
from the ephrin-presenting surface. When grids with
narrower pitches are prepatterned onto the underlying sub-
strate, the cytoskeleton displays a spreading morphology,
suggesting mesenchymal cell behavior (45). Using total
internal reflection fluorescence, which excites fluorophores
within 70–100 nm of the cell-SLB interface thereby elimi-
nating a majority of the intracellular fluorescence signal
(32), increasing ADAM10 recruitment is observed when
Eph-ephrin transport is less hindered (Fig. 5, B and C).The density of EphA2 on the membrane surface is equal
across the different pitched corrals, suggesting that EphA2
recruitment to the cell membrane is unaffected by the Cr
grids (Fig. 5 C). These findings suggest that EphA2 signal-
ing is sensitive to the lateral organization of membrane
mEA1. Furthermore, this signaling pathway exhibits a
dependency on the spatio-mechanical organization of the
EphA2 receptor.CONCLUSION
Monomeric ephrin-A1 displayed on a supported membrane
successfully triggers EphA2 in living cells. Importantly, this
system enables observations of natural receptor ligand clus-
tering and assembly processes, as driven by the EphA2
receptor expressing cell. We affirm some fundamental ob-
servations concerning influences of mechanical constraints
of ephrin-A1 ligand movement on EphA2 signaling, which
had been originally reported using only chemically cross-
linked ephrin-A1 ligands. The findings presented here con-
firm that the spatio-mechanical sensitivity we discovered in
the EphA2 signaling pathway is not due to the chemical
cross-linking of ephrin-A1 from using a streptavidin-biotin
linkage. However, some differences in the kinetics of
assembly are also noted between the two systems. ThroughFIGURE 5 EphA2 pathway activated by mEA1
shows a spatio-mechanical regulatory component.
(A) Ligand-induced EphA2 clustering is restricted
with chromium barriers. Epifluorescence images
show cytoskeleton annulus formation when trans-
port is unrestricted and cytoskeleton spreading
morphology when transport is restricted. (B) Total
internal reflection fluorescence microscopy and
(C) subsequent quantitative colocalization analysis
of EphA2 to ADAM10 reveals that ADAM10
recruitment occurs only when receptor transport
is unhindered. An average of 200 cells was
analyzed for each grid pitch. The surface density
of mEA1 used for these experiments is approxi-
mately hundreds of molecules/mm2. Scale bars
are 10 mm.
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2738 Xu et al.the use of a monomeric fluorescent fusion protein of ephrin-
A1, we are able to examine the initial steps of Eph-ephrin
clustering and transport that have been shown to play vital
roles in signal transduction and is functionally altered in
cancerous cells.SUPPORTING MATERIAL
Eleven figures, Materials and Methods, and references are available at
http://www.biophysj.org/biophysj/supplemental/S0006-3495(11)01261-6.
The authors thank Pradeep M. Nair and Michael P. Coyle for critical
reading of the manuscript. The authors also thank JoeW. Gray for providing
the Western blotting equipment and Odyssey Infrared Imaging machine.
This work was supported by the Director, Office of Science, Office of Basic
Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Divi-
sion (Q.X.; hybrid synthetic-live cell interfaces) and the Materials Sciences
and Engineering Division (R.S.P.; supported membrane substrates) of the
U.S. Department of Energy (DOE) under contract no. DE-AC02-
05CH11231. Patterned substrate fabrication was performed, in part, at the
Molecular Foundry (or National Center for Electron Microscopy), Law-
rence Berkeley National Laboratory (LBNL), and was supported by the
Office of Science, Office of Basic Energy Sciences, Scientific User Facili-
ties Division, of the U.S. DOE under contract no. DE-AC02-05CH11231.
This work was also supported by the Laboratory Directed Research and
Development Program of LBNL under U.S. DOE contract no. DE-AC02-
05CH11231. Seed support for biomedical aspects of this work was provided
by the U.S. Department of Defense DA Congressionally Directed Medical
Research Program Idea Award BC102681 under U.S. Army Medical
Research Acquisition Activity no. W81XWH-11-1-0256, with follow-on
support provided by Award U54 CA143836 from the National Cancer Insti-
tute (NCI) beginning in 2009. The content is solely the responsibility of the
authors and does not necessarily represent the official views of the NCI or
the National Institutes of Health.REFERENCES
1. Lackmann, M., and A. W. Boyd. 2008. Eph, a protein family coming of
age: more confusion, insight, or complexity? Sci. Signal. 1:re2.
2. Mosch, B., B. Reissenweber, C. Neuber, and J. Pietzsch. 2010. Eph
receptors and ephrin ligands: important players in angiogenesis and
tumor angiogenesis. J. Oncol. 2010:135285.
3. Wykosky, J., and W. Debinski. 2008. The EphA2 receptor and
ephrinA1 ligand in solid tumors: function and therapeutic targeting.
Mol. Cancer Res. 6:1795–1806.
4. Kinch, M. S., and K. Carles-Kinch. 2003. Overexpression and func-
tional alterations of the EphA2 tyrosine kinase in cancer. Clin. Exp.
Metastasis. 20:59–68.
5. Zelinski, D. P., N. D. Zantek, ., M. S. Kinch. 2001. EphA2 overex-
pression causes tumorigenesis of mammary epithelial cells. Cancer
Res. 61:2301–2306.
6. Carles-Kinch, K., K. E. Kilpatrick, ., M. S. Kinch. 2002. Antibody
targeting of the EphA2 tyrosine kinase inhibits malignant cell behavior.
Cancer Res. 62:2840–2847.
7. Guo, H., H. Miao, ., B. Wang. 2006. Disruption of EphA2 receptor
tyrosine kinase leads to increased susceptibility to carcinogenesis in
mouse skin. Cancer Res. 66:7050–7058.
8. Himanen, J. P., K. R. Rajashankar, ., D. B. Nikolov. 2001. Crystal
structure of an Eph receptor-ephrin complex. Nature. 414:933–938.
9. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell.
103:211–225.Biophysical Journal 101(11) 2731–273910. Janes, P. W., N. Saha, ., D. B. Nikolov. 2005. Adam meets Eph: an
ADAM substrate recognition module acts as a molecular switch for
ephrin cleavage in trans. Cell. 123:291–304.
11. Smith, F. M., C. Vearing,., A. W. Boyd. 2004. Dissecting the EphA3/
Ephrin-A5 interactions using a novel functional mutagenesis screen.
J. Biol. Chem. 279:9522–9531.
12. Salaita, K., P. M. Nair, ., J. T. Groves. 2010. Restriction of receptor
movement alters cellular response: physical force sensing by EphA2.
Science. 327:1380–1385.
13. Zhuang, G., S. Hunter, ., J. Chen. 2007. Regulation of EphA2
receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylino-
sitol 3-Kinase-dependent Rac1 activation. J. Biol. Chem. 282:2683–
2694.
14. Himanen, J. P., L. Yermekbayeva,., S. Dhe-Paganon. 2010. Architec-
ture of Eph receptor clusters. Proc. Natl. Acad. Sci. USA. 107:10860–
10865.
15. Grakoui, A., S. K. Bromley,., M. L. Dustin. 1999. The immunolog-
ical synapse: a molecular machine controlling T cell activation.
Science. 285:221–227.
16. Mossman, K. D., G. Campi, ., M. L. Dustin. 2005. Altered TCR
signaling from geometrically repatterned immunological synapses.
Science. 310:1191–1193.
17. Manz, B. N., and J. T. Groves. 2010. Spatial organization and signal
transduction at intercellular junctions. Nat. Rev. Mol. Cell Biol.
11:342–352.
18. DeMond, A. L., K. D. Mossman,., J. T. Groves. 2008. T cell receptor
microcluster transport through molecular mazes reveals mechanism of
translocation. Biophys. J. 94:3286–3292.
19. Sackmann, E. 1996. Supported membranes: scientific and practical
applications. Science. 271:43–48.
20. Richter, R. P., R. Be´rat, and A. R. Brisson. 2006. Formation of solid-
supported lipid bilayers: an integrated view. Langmuir. 22:3497–3505.
21. Macha´n, R., and M. Hof. 2010. Lipid diffusion in planar membranes
investigated by fluorescence correlation spectroscopy. Biochim.
Biophys. Acta. 1798:1377–1391.
22. Groves, J. T., N. Ulman, and S. G. Boxer. 1997. Micropatterning fluid
lipid bilayers on solid supports. Science. 275:651–653.
23. Groves, J. T., C. Wu¨lfing, and S. G. Boxer. 1996. Electrical manipula-
tion of glycan-phosphatidyl inositol-tethered proteins in planar sup-
ported bilayers. Biophys. J. 71:2716–2723.
24. Groves, J. T., and M. L. Dustin. 2003. Supported planar bilayers in
studies on immune cell adhesion and communication. J. Immunol.
Methods. 278:19–32.
25. Dorn, I. T., K. R. Neumaier, and R. Tampe´. 1998. Molecular recogni-
tion of histidine-tagged molecules by metal-chelating lipids monitored
by fluorescence energy transfer and correlation spectroscopy. J. Am.
Chem. Soc. 120:2753–2763.
26. Nye, J. A., and J. T. Groves. 2008. Kinetic control of histidine-tagged
protein surface density on supported lipid bilayers. Langmuir. 24:4145–
4149.
27. Lackmann, M., R. J. Mann, ., A. W. Boyd. 1997. Ligand for EPH-
related kinase (LERK) 7 is the preferred high affinity ligand for the
HEK receptor. J. Biol. Chem. 272:16521–16530.
28. Davis, S., N. W. Gale,., G. D. Yancopoulos. 1994. Ligands for EPH-
related receptor tyrosine kinases that require membrane attachment or
clustering for activity. Science. 266:816–819.
29. Wykosky, J., E. Palma, ., W. Debinski. 2008. Soluble monomeric
EphrinA1 is released from tumor cells and is a functional ligand for
the EphA2 receptor. Oncogene. 27:7260–7273.
30. Boniface, J. J., J. D. Rabinowitz, ., M. M. Davis. 1998. Initiation
of signal transduction through the T cell receptor requires the multiva-
lent engagement of peptide/MHC ligands [corrected]. Immunity.
9:459–466.
31. Baksh, M. M., C. Dean, ., J. T. Groves. 2005. Neuronal activation
by GPI-linked neuroligin-1 displayed in synthetic lipid bilayer
membranes. Langmuir. 21:10693–10698.
EphA2 Activation by Monomeric Ephrin-A1 273932. Groves, J. T., R. Parthasarathy, and M. B. Forstner. 2008. Fluorescence
imaging of membrane dynamics. Annu. Rev. Biomed. Eng. 10:311–338.
33. Lakowicz, J. R. 1991. Topics in Fluorescence Spectroscopy. Plenum
Press, New York.
34. Moran, U., R. Phillips, and R. Milo. 2010. SnapShot: key numbers in
biology. Cell. 141:1262–1262.e1.
35. Meseth, U., T. Wohland,., H. Vogel. 1999. Resolution of fluorescence
correlation measurements. Biophys. J. 76:1619–1631.
36. Saffman, P. G., and M. Delbru¨ck. 1975. Brownian motion in biological
membranes. Proc. Natl. Acad. Sci. USA. 72:3111–3113.
37. Naji, A., A. J. Levine, and P. A. Pincus. 2007. Corrections to the
Saffman-Delbruck mobility for membrane bound proteins. Biophys. J.
93:L49–L51.
38. Chen, Y., J. D. Mu¨ller,., E. Gratton. 1999. The photon counting histo-
gram in fluorescence fluctuation spectroscopy. Biophys. J. 77:553–567.
39. Galush, W. J., J. A. Nye, and J. T. Groves. 2008. Quantitative fluores-
cence microscopy using supported lipid bilayer standards. Biophys. J.
95:2512–2519.40. Mu¨ller, J. D., Y. Chen, and E. Gratton. 2000. Resolving heterogeneity
on the single molecular level with the photon-counting histogram.
Biophys. J. 78:474–486.
41. Hartman, N. C., J. A. Nye, and J. T. Groves. 2009. Cluster size regu-
lates protein sorting in the immunological synapse. Proc. Natl. Acad.
Sci. USA. 106:12729–12734.
42. Neve, R. M., K. Chin, ., J. W. Gray. 2006. A collection of breast
cancer cell lines for the study of functionally distinct cancer subtypes.
Cancer Cell. 10:515–527.
43. Murphy, R. M., H. Slayter,., M. L. Yarmush. 1988. Size and structure
of antigen-antibody complexes. Electron microscopy and light scat-
tering studies. Biophys. J. 54:45–56.
44. Nievergall, E., P. W. Janes,., M. Lackmann. 2010. PTP1B regulates
Eph receptor function and trafficking. J. Cell Biol. 191:1189–1203.
45. Symons, M., and J. E. Segall. 2009. Rac and Rho driving tumor
invasion: who’s at the wheel? Genome Biol. 10:213.Biophysical Journal 101(11) 2731–2739
